Search

Showing "11155" results for ""

Immune changes in exposed, uninfected partners of people with HIV correlate with partner’s viral load

Dry skin affects up to half of adults with HIV

High incidence of STIs in HIV-positive young American women

Rare gene causes massive increases in efavirenz levels in twelve-year-old leading to psychosis

Protein in spinal fluid can be a marker of HIV dementia

Kenya: treatment literacy lagging behind ARV rollout

Uganda: factory to boost ARV rollout

New Swedish chlamydia strain ‘possible emerging threat to public health’

HIV-related symptoms significantly reduced three weeks after quitting smoking

Stigma surrounding genital herpes a major barrier to disclosure, UK study finds

Studies underway to find the best time to start anti-HIV therapy in those taking TB treatment

Sudden increases in viral load in first two years of infection could indicate superinfection

Good virological outcome in patients starting HIV therapy in the UK

Raltegravir receives accelerated approval from the FDA

Cluster of 'indolent' KS cases in older, antiretroviral-treated patients in San Francisco

Up to 40% of ART recipients in Africa have died or discontinued treatment within two years

Why are many US patients presenting later for HIV testing and care today than in 1990?

Palliative care: pain and symptom control being ignored in South Africa due to lack of training, legal barriers

Receive the latest HIV research and conference news

Showing "11155" results for ""

Immune changes in exposed, uninfected partners of people with HIV correlate with partner’s viral load

Dry skin affects up to half of adults with HIV

High incidence of STIs in HIV-positive young American women

Rare gene causes massive increases in efavirenz levels in twelve-year-old leading to psychosis

Protein in spinal fluid can be a marker of HIV dementia

Kenya: treatment literacy lagging behind ARV rollout

Uganda: factory to boost ARV rollout

New Swedish chlamydia strain ‘possible emerging threat to public health’

HIV-related symptoms significantly reduced three weeks after quitting smoking

Stigma surrounding genital herpes a major barrier to disclosure, UK study finds

Studies underway to find the best time to start anti-HIV therapy in those taking TB treatment

Sudden increases in viral load in first two years of infection could indicate superinfection

Good virological outcome in patients starting HIV therapy in the UK

Raltegravir receives accelerated approval from the FDA

Cluster of 'indolent' KS cases in older, antiretroviral-treated patients in San Francisco

Up to 40% of ART recipients in Africa have died or discontinued treatment within two years

Why are many US patients presenting later for HIV testing and care today than in 1990?

Palliative care: pain and symptom control being ignored in South Africa due to lack of training, legal barriers

Receive the latest HIV research and conference news